Ignite Creation Date:
2024-05-06 @ 7:08 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05903924
Status:
RECRUITING
Last Update Posted:
2024-03-21
First Post:
2023-06-05
Brief Title:
Motion Serifos A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
Sponsor:
Vanda Pharmaceuticals
Organization:
Vanda Pharmaceuticals
Study Overview
Official Title:
Motion Serifos A Randomized Double-blind Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A multi-center randomized double-blind placebo-controlled study to investigate the efficacy of tradipitant in participants affected by motion sickness during travel
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None